Treatments for relapsing and/or refractory multiple myeloma. A health technology assessment
dc.contributor.author | Desser, Arna S. | |
dc.contributor.author | Ohm, Ingrid Kristine | |
dc.contributor.author | Rose, Christopher James | |
dc.contributor.author | Chaudhry, Fawaz Tariq | |
dc.contributor.author | Næss, Gunn Eva | |
dc.contributor.author | Giske, Liv | |
dc.contributor.author | Fretheim, Atle | |
dc.date.accessioned | 2023-05-08T06:06:50Z | |
dc.date.available | 2023-05-08T06:06:50Z | |
dc.date.created | 2023-03-23T12:27:34Z | |
dc.date.issued | 2023 | |
dc.identifier.isbn | 978-82-8406-364-5 | |
dc.identifier.uri | https://hdl.handle.net/11250/3066668 | |
dc.language.iso | eng | |
dc.publisher | Folkehelseinstituttet. Område for helsetjenester | |
dc.relation.uri | https://www.fhi.no/publ/2023/behandlinger-av-relapserende-ogeller-refraktar-myelomatose/ | |
dc.subject | Myelomatose | |
dc.subject.mesh | Thalidomide | |
dc.subject.mesh | Multiple Myeloma | |
dc.subject.mesh | Bortezomib | |
dc.subject.mesh | Lenalidomide | |
dc.subject.mesh | Panobinostat | |
dc.subject.mesh | Pomalidomide | |
dc.title | Treatments for relapsing and/or refractory multiple myeloma. A health technology assessment | |
dc.title.alternative | Behandlinger av relapserende og/eller refraktær myelomatose: En fullstendig metodevurdering | |
dc.title.alternative | ||
dc.type | Research report | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 248 | |
dc.identifier.cristin | 2136402 | |
cristin.ispublished | true | |
cristin.fulltext | original |